Quick Answer
Hepion Pharmaceuticals, Inc. reported Stockholders Equity of $2.67 million for the year ending 2025.
- Hepion Pharmaceuticals, Inc. showed an increase of +243.2% in Stockholders Equity from 2024 to 2025.
- This data is from Hepion Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2013 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: -$322.6 thousand | Q4 2013: -$489.9 thousand | Q1 2014: -$7.34 million | Q3 2014: $539.9 thousand | Q4 2014: $8.60 million | Q1 2015: $7.88 million | Q3 2015: -$1.36 million | Q4 2015: $4.98 million | Q1 2016: $1.30 million | Q3 2016: -$3.00 million | Q4 2016: $5.88 million | Q1 2017: -$385.4 thousand | Q3 2017: $4.99 million | Q1 2018: $3.05 million | Q2 2018: -$752.6 thousand | Q3 2018: $4.65 million | Q1 2019: $394.8 thousand | Q2 2019: $17.78 million | Q3 2019: $15.98 million | Q1 2020: $18.20 million | Q2 2020: $17.72 million | Q3 2020: $12.87 million | Q1 2021: $117.58 million | Q2 2021: $110.72 million | Q3 2021: $102.64 million | Q1 2022: $86.64 million | Q2 2022: $67.32 million | Q3 2022: $59.26 million | Q1 2023: $37.15 million | Q2 2023: $26.37 million | Q3 2023: $16.16 million | Q1 2024: $7.52 million | Q2 2024: $3.56 million | Q3 2024: $406.7 thousand | Q1 2025: $3.90 million | Q2 2025: $3.80 million | Q3 2025: $3.32 million.
- Over the full 17 years of available data (2013 to 2025), Hepion Pharmaceuticals, Inc.'s Stockholders Equity has grown by 1,998.7%.
- Historical annual values: Fiscal year 2025: $2.67 million | Fiscal year 2024: -$1.86 million | Fiscal year 2023: $7.28 million | Fiscal year 2022: $49.86 million | Fiscal year 2021: $93.00 million | Fiscal year 2021: $102.64 million | Fiscal year 2021: $110.72 million | Fiscal year 2021: $117.58 million | Fiscal year 2020: $40.52 million | Fiscal year 2019: $15.62 million | Fiscal year 2018: $1.72 million | Fiscal year 2017: $3.70 million | Fiscal year 2017: $9.06 million | Fiscal year 2016: $1.32 million | Fiscal year 2015: $3.44 million | Fiscal year 2014: -$2.93 million | Fiscal year 2013: -$140.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: